Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2025

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Presenter: Gerald S. Werner

October 25, 2025

Presentation TCT 2018

Data Analysis: The Big Three Trials - Decision CTO, EURO CTO, OPEN CTO

Presenter: John A. Spertus, Robert W. Yeh, Ajay J. Kirtane

September 24, 2018

Presentation TCTAP 2018

DECISION-CTO: Updated QOL and Long-Term Outcomes

Presenter: Seung-Whan Lee

April 28, 2018

Presentation CTO 2018

Decision CTO, EURO CTO, OPEN CTO

Presenter: Gregg W. Stone, Ajay J. Kirtane

February 16, 2018

Presentation TTT 2018

Should we revascularized CTO lesions? Decision CTO vs Euro CTO trial

Presenter: Alfredo R. Galassi

January 14, 2018

Presentation TCT 2017

DECISION-CTO and EURO-CTO: Critique and Unanswered Questions

Presenter: David J. Cohen, Ajay J. Kirtane, Emmanouil S. Brilakis

November 01, 2017

Presentation TCT 2017

DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications

Presenter: David J. Cohen, Ajay J. Kirtane, Gerald S. Werner

November 01, 2017

Presentation TCT 2017

Outcomes and Clinical Implications From DECISION-CTO

Presenter: Barry D. Rutherford, Robert W. Yeh, Seung-Whan Lee

October 31, 2017

Presentation TCT 2017

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

Presenter: Roxana Mehran, Robert W. Yeh, Laura Mauri

October 30, 2017

Presentation ACC 2017

DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion

Presenter: Seung-Jung Park

March 20, 2017

Presentation TCT 2016

Should Every CTO Be Opened? From the IRIS-CTO Registry to the Randomized (DECISION-CTO Trial)

Presenter: Seung-Jung Park, Alan C. Yeung, Seung-Whan Lee

October 31, 2016

Advertisement

Revascularization vs. Optimal Medical Therapy of Chronic Total Occlusions for Symptom Relief and Quality of Life: From the EUROCTO and DECISION-CTO Randomized Trials

Data Analysis: The Big Three Trials - Decision CTO, EURO CTO, OPEN CTO

DECISION-CTO: Updated QOL and Long-Term Outcomes

Decision CTO, EURO CTO, OPEN CTO

Should we revascularized CTO lesions? Decision CTO vs Euro CTO trial

DECISION-CTO and EURO-CTO: Critique and Unanswered Questions

DECISION-CTO and EURO-CTO: Topline Findings and Practice Implications

Outcomes and Clinical Implications From DECISION-CTO

How to Interpret Trials That Are Stopped Early (eg, PRAMI, FAME II, DECISION CTO, and Others)

DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion

Should Every CTO Be Opened? From the IRIS-CTO Registry to the Randomized (DECISION-CTO Trial)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content